Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000558321 | SCV000640212 | likely pathogenic | Charcot-Marie-Tooth disease axonal type 2F | 2024-11-15 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 124 of the HSPB1 protein (p.His124Gln). This variant is present in population databases (rs145243219, gnomAD 0.01%). This missense change has been observed in individuals with clinical features of autosomal dominant Charcot-Marie-Tooth disease and/or distal hereditary motor neuropathy (PMID: 32376792; internal data). ClinVar contains an entry for this variant (Variation ID: 465273). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on HSPB1 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Athena Diagnostics | RCV000711974 | SCV000842385 | uncertain significance | not provided | 2018-01-25 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172546 | SCV001335607 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000711974 | SCV001820623 | uncertain significance | not provided | 2022-02-09 | criteria provided, single submitter | clinical testing | Reported as a variant of uncertain significance in two patients with Charcot-Marie-Tooth disease in published literature (Volodarsky et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32376792) |
Ce |
RCV000711974 | SCV002563956 | uncertain significance | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | HSPB1: PM1, PP3, PP4 |
MGZ Medical Genetics Center | RCV000558321 | SCV002579513 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2F | 2022-03-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350273 | SCV002620345 | likely benign | Inborn genetic diseases | 2021-08-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |